
News|Podcasts|June 3, 2025
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
Author(s)Alexandra Gerlach, Associate Editor
Experts share insights on patient discussions and adverse effect management strategies in HER2 breast cancer.
Advertisement
Listen to the final episode in our Pharmacy Times Peer Exchange feature series on antibody-drug conjugates and HER2 breast cancer. In this segment, our pharmacy experts share how they have discussions with patients about treatment and interdisciplinary approaches to managing adverse effects to enhance patient care.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Once-Weekly Retatrutide Reduces Weight and Knee Pain in Patients With Obesity and Osteoarthritis
2
FDA Approves Lerodalcibep for Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia
3
FDA Approves T-DXd With Pertuzumab for First-Line Treatment of Advanced HER2+Breast Cancer
4
FDA Approval Signals Broader Recognition of Sexual Health in Aging Women
5

















































































































































































































